Immupharma Share Discussion Threads

[l0ngterm] 21/12/2017 17:25

Was just pondering the consultants and options granted, and these consultants could feasible be the scientific advisory board. Which logically would make sense, based upon the below (based on startups, but applicable here)."So, how should your startups' Advisory Board Member be compensated?Stock options between 0.1% and 1.0% of company equity are typical for startups in the Concept and Seed stages of development. This could also apply to Early stage ventures. The awards are generally skewed to the upper side for higher quality Advisors whose level of participation is stronger."https://fundingsage.com/3-considerations-for-advisory-board-compensation/For this interested a link on scientific advisory boards.https://www.google.co.uk/amp/s/www.forbes.com/sites/brucebooth/2012/09/10/biotech-scientific-advisory-boards-what-works-what-doesnt/amp/

[sportbilly1976] 21/12/2017 16:10

a mix of that and stop fishing too...15% was the low hit yesterday

[hamhamham1] 21/12/2017 16:05

Yep i dont think the proposed option holders would want to bother. Maybe just nobby brokers doing it independently to impress their clients?
Or I might have an overactive imagination.

[obiterdicta] 21/12/2017 16:01

If the share price goes to £50.00 or even £5.00 - the difference between an option priced at £1.60 compared to £1.40 will be nominal - so not very impressive manouvere.

OD

[hamhamham1] 21/12/2017 15:52

So on my head I imagine the drop was the result of over zealous brokers of the proposed option holders. The brokers trying to score some brownie points with their client.
But I reckon it was so blatent that IMM got a whiff and slapped them down, telling the proposed options holders to get the share price back to where it was.
Forcing the original brokers to buy back in and bringing the share price back up.
Today being a gentle sell off of the brokers own forced holding.
Hopefully now we can get back on path as normal programming is resumed :)

[topdiesel] 21/12/2017 15:23

you are not a cynic. That is exactly what happened.

[sportbilly1976] 21/12/2017 15:22

hamham,

+1 for that...just seemed too coincidental, even at the time I felt there was a coerced force behind the move. Prices don't just drop 10-15% on no news or rumour of news

[hamhamham1] 21/12/2017 15:20

And the cynic inside me says that's why there was a huge attempt to drop the share price yesterday in order to get the lowest option price at closing.

[hamhamham1] 21/12/2017 15:14

I wonder if that in the absence of any more news then the new floor price will be 153p.
This is the option price in today's rns and is the latest indicator of a minimal price beyond the daily buy and sells.
Time will tell but I hope it is the case.
WTFDIK.

[ashehzi] 21/12/2017 14:48

Today volume is almost same as average volume.

[sportbilly1976] 21/12/2017 14:27

could be anyone - a few top-slicers as mentioned, some maybe who bought yesterday and are banking a 24 hour 10% gain?

the volume isn't significant today though, just over 400k

[farmsted] 21/12/2017 14:26

There is a lot of buys today,who is selling ??

[top tips] 21/12/2017 14:25

I think it is pretty obvious they will issue another Update next month confirming last patient evaluation and trial end.

[lukead] 21/12/2017 14:21

And GF, obviously you must have sold any holding you had

[l0ngterm] 21/12/2017 14:17

Gf: interesting input, so basically a test of nerves for the current holders.What's your thoughts on trial completion RNS being issued, and then a broker re-rate, in relation to price movement?

[greedfear] 21/12/2017 14:04

Sportbilly- it has, as I expected. That's why I think a retest is likely.

[waterloo01] 21/12/2017 13:35

If there's going to be a deal pre results, this should be the trigger, although as we are now 6-8 weeks from results, probably more likely will go into the results with full ownership.

[sportbilly1976] 21/12/2017 12:38

Wed, Thursday next week normal...12:30pm close tomorrow/next Friday

[che7win] 21/12/2017 12:31

Half day tomorrow, off Mon/Tues, half day 29th.

[divinessence] 21/12/2017 12:29

I think most people will see the RNS and gain confidence to add more. IMM have been spot on in their communication. Next stop £2.00+ unless their is offer which could well come any time as all is in place.

[immy1992] 21/12/2017 12:24

could someone tell me what the trading hours are tomorrow and possibly next tuesday/wednesday. Thank you

[sportbilly1976] 21/12/2017 12:11

greedfear,

Wasn't 136p tested (albeit briefly) yesterday?

[quiche66] 21/12/2017 12:08

The Trump Tax Bill should be good news for IMM. Will mean lots of M&A activity as big pharmas will repatriate their massive foreign holdings and more likely to go after some deals - like buying out IMM. All presuming ph3 results are good of course.

[top tips] 21/12/2017 12:07

"In Mar 2009, HGSi shares (on their 50% stake in lupus drug Benlysta) were $0.45, becoming $3.23 (market cap $528m) early Jul 2009 just before PIII Benlysta results, $12.51 (market cap of $2 billion+) at close on results day late Jul 2009, and $34.49 ($6.46 billion market cap, as there was also some dilution) at peak in Apr 2010 = 76x return over 13 months from peak low to peak high."

[greedfear] 21/12/2017 12:06

lukead- no agenda. It's just that I think I know some of the biotech investing psychology. A lot of people are waiting for a RNS to derisk. Because of that the RNS often causes a downward pressure. Also this RNS was not unexpected.
Reading the BB I believe almost everyone that wants shares, have them (a lot having overweight positions is my guess). Fresh blood is hard to find, so who are you going to sell to if you want to derisk?. No doubt there will be further derisking. 136p is the test. Next stop will be 100p.

Can be wrong and have been many times before.